Robert Horsburgh
Profiles

Charles R Horsburgh, Jr, MD

Professor, Global Health - Boston University School of Public Health

(617) 358-3758
rhorsbu@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is a member of the Board of Directors of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Other Positions

  • Professor, Epidemiology - Boston University School of Public Health
  • Professor, Biostatistics - Boston University School of Public Health
  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
  • - Boston Medical Center

Education

  • Case Western Reserve University, MD Field of Study: Medicine
  • Yale University, MS Field of Study: Urban Studies
  • Princeton University, AB Field of Study: Architecture

Websites

Classes Taught

  • SPHEP730
  • SPHEP764
  • SPHEP784
  • SPHEP911
  • SPHGH941

Publications

  • Published on 5/8/2024

    Martinez L, Seddon JA, Horsburgh CR, Lange C, Mandalakas AM. Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies. Lancet Respir Med. 2024 May 08. PMID: 38734022.

     Read At: PubMed
  • Published on 4/23/2024

    Sinha P, Ezhumalai K, Du X, Ponnuraja C, Dauphinais MR, Gupte N, Sarkar S, Gupta A, Gaikwad S, Thangakunam B, Paradkar M, Christopher DJ, Mave V, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR, Padmapriyadarsini C, Gupte A. Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection- a Multicenter Prospective Cohort Analysis. Clin Infect Dis. 2024 Apr 23. PMID: 38652286.

     Read At: PubMed
  • Published on 4/2/2024

    Li Y, Regan M, Swartwood NA, Barham T, Beeler Asay GR, Cohen T, Hill AN, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data. Ann Intern Med. 2024 Apr; 177(4):418-427. PMID: 38560914.

     Read At: PubMed
  • Published on 3/24/2024

    Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR, Murray M, Lange C. Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024 Mar 24; 10(1):22. PMID: 38523140.

     Read At: PubMed
  • Published on 3/1/2024

    Yamkovoy K, Self JL, Jenkins HE, Horsburgh CR, White LF. Patterns of TB transmission in the United States, 2011-2017. Int J Tuberc Lung Dis. 2024 Mar 01; 28(3):154-156. PMID: 38454181.

     Read At: PubMed
  • Published on 3/1/2024

    Leavitt SV, Rodriguez CA, Bouton TC, Horsburgh CR, Abel Zur Wiesch P, Nichols BE, White LF, Jenkins HE. Outcomes for people with TB by disease severity at presentation. Int J Tuberc Lung Dis. 2024 Mar 01; 28(3):142-147. PMID: 38454178.

     Read At: PubMed
  • Published on 1/1/2024

    Rodriguez CA, Horsburgh CR, Jenkins HE, White LF. Reply to 'Estimating TB survival - mind the immortal-time gap'. Int J Tuberc Lung Dis. 2024 Jan 01; 28(1):66-67. PMID: 38178287.

     Read At: PubMed
  • Published on 1/1/2024

    Sinha P, Dauphinais M, Carwile ME, Horsburgh CR, Menzies NA. In-kind nutritional supplementation for household contacts of persons with tuberculosis would be cost-effective for reducing tuberculosis incidence and mortality in India: a modeling study. medRxiv. 2024 Jan 01. PMID: 38260435.

     Read At: PubMed
  • Published on 1/1/2024

    Regan M, Li Y, Swartwood NA, Barham T, Asay GRB, Cohen T, Hill AN, Horsburgh CR, Khan A, Marks SM, Myles RL, Salomon JA, Self JL, Menzies NA. Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003-19: an analysis of national surveillance data. Lancet Public Health. 2024 Jan; 9(1):e47-e56. PMID: 38176842.

     Read At: PubMed
  • Published on 12/1/2023

    du Cros P, Greig J, Alffenaar JC, Cross GB, Cousins C, Berry C, Khan U, Phillips PPJ, Velásquez GE, Furin J, Spigelman M, Denholm JT, Thi SS, Tiberi S, Huang GKL, Marks GB, Turkova A, Guglielmetti L, Chew KL, Nguyen HT, Ong CWM, Brigden G, Singh KP, Motta I, Lange C, Seddon JA, Nyang'wa BT, Maug AKJ, Gler MT, Dooley KE, Quelapio M, Tsogt B, Menzies D, Cox V, Upton CM, Skrahina A, McKenna L, Horsburgh CR, Dheda K, Marais BJ. Standards for clinical trials for treating TB. Int J Tuberc Lung Dis. 2023 Dec 01; 27(12):885-898. PMID: 38042969.

     Read At: PubMed

View 345 more publications:View Full Profile at BUMC

News & In the Media

View all profiles